Latest database descriptions

The objectives of the Sentinel Network, defined at its launching, were the following:
- Monitoring, year after year, perinatal health indicators (indicators of recruitment, practice and results) by combining data from maternity wards participating in the network:
- Providing maternity wards with a tool to evaluate their practices and results, comparing the results of the analysis realized with their own records with the Sentinel network records;
- Launching multicenter studies, at one of the network members' request.

The main objective of this study is to design, in an intent-to-transplant approach, liver graft allocation models to optimize the ECG-recipient matching and to provide a decision-making algorithm for ECG utilization. Such models aim at improving the efficiency of the French system of allocation and to limit the consequences or organ shortage

This study aims to develop prototype tests for the in vitro diagnostic serology of SARS-CoV-2

The main aim of the EPHEGREN study is to assess the pharmacoeconomic impact of different immunosuppressive strategies (IS) on kidney transplant patients from a hospital, health insurance and societal perspective.
The secondary objectives of the EPHEGREN study:
To assess the cost-effectiveness of different preventative and curative strategies for reactivation and cytomegalovirus (CMV) disease in CMV+ kidney transplant patients (serologic status of recipient when receiving transplant) from a hospital, health insurance and societal perspective.
To determine predictive pharmacological factors for long-term renal function outcome.
To determine predictive pharmacological factors for the onset of cancer, diabetes and cardiovascular diseases.
To validate the impact of genetic polymorphisms on metabolic enzymes, membrane transporters and proteins targeting immunosuppressants on exposure and the therapeutic and side effects of treatment.
To prospectively validate urinary biomarker candidates for current or future acute rejection, or for chronic renal allograft dysfunction.